Marth C - Search Results

1

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, Mueller-Holzner E, Corcoran M, Dagnell M, Nejad SZ, Nayer BN, Zali MR, Hansson J, Egyhazi S, Petersson F, Sangfelt P, Nordgren H, Grander D, Reed SI, Widschwendter M, Sangfelt O, Spruck C. Akhoondi S, et al. Among authors: marth c. Cancer Res. 2007 Oct 1;67(19):9006-12. doi: 10.1158/0008-5472.CAN-07-1320. Cancer Res. 2007. PMID: 17909001

2

Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.

Widschwendter M, Daxenbichler G, Dapunt O, Marth C. Widschwendter M, et al. Among authors: marth c. Cancer Res. 1995 May 15;55(10):2135-9. Cancer Res. 1995. PMID: 7743514

3

Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.

Marth C, Zeimet AG, Widschwendter M, Ludescher C, Kaern J, Tropé C, Gastl G, Daxenbichler G, Dapunt O. Marth C, et al. Cancer Res. 1997 Sep 1;57(17):3818-22. Cancer Res. 1997. PMID: 9288793

4

Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.

Widschwendter M, Berger J, Daxenbichler G, Müller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG. Widschwendter M, et al. Among authors: marth c. Cancer Res. 1997 Oct 1;57(19):4158-61. Cancer Res. 1997. PMID: 9331065

5

Regulation of CA 125 expression in cultured human carcinoma cells.

Marth C, Zeimet AG, Widschwendter M, Daxenbichler G. Marth C, et al. Int J Biol Markers. 1998 Oct-Dec;13(4):207-9. Int J Biol Markers. 1998. PMID: 10228902 Review.

6

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

Abendstein B, Marth C, Müller-Holzner E, Widschwendter M, Daxenbichler G, Zeimet AG. Abendstein B, et al. Among authors: marth c. Cancer. 2000 Mar 15;88(6):1432-7. doi: 10.1002/(sici)1097-0142(20000315)88:6<1432::aid-cncr22>3.0.co;2-8. Cancer. 2000. PMID: 10717627

7

Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.

Widschwendter M, Berger J, Müller HM, Zeimet AG, Marth C. Widschwendter M, et al. Among authors: marth c. J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):193-201. doi: 10.1023/a:1011360724350. J Mammary Gland Biol Neoplasia. 2001. PMID: 11501579 Review.

8

Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HER2 status of the whole tumor.

Mueller-Holzner E, Fink V, Frede T, Marth C. Mueller-Holzner E, et al. Among authors: marth c. Breast Cancer Res Treat. 2001 Sep;69(1):13-9. doi: 10.1023/a:1012281221647. Breast Cancer Res Treat. 2001. PMID: 11759824 Clinical Trial.

9

hCDC4 gene mutations in endometrial cancer.

Spruck CH, Strohmaier H, Sangfelt O, Müller HM, Hubalek M, Müller-Holzner E, Marth C, Widschwendter M, Reed SI. Spruck CH, et al. Among authors: marth c. Cancer Res. 2002 Aug 15;62(16):4535-9. Cancer Res. 2002. PMID: 12183400

10

Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.

Ott HW, Lindner H, Sarg B, Mueller-Holzner E, Abendstein B, Bergant A, Fessler S, Schwaerzler P, Zeimet A, Marth C, Illmensee K. Ott HW, et al. Among authors: marth c. Cancer Res. 2003 Nov 1;63(21):7507-14. Cancer Res. 2003. PMID: 14612552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

480 results

Search Page